• 393 Citations
  • 10 h-Index
20092015
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Syed Mohammad Ali Kazmi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Mutation Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Sweet Syndrome Medicine & Life Sciences
Molecular Targeted Therapy Medicine & Life Sciences
Melphalan Medicine & Life Sciences

Research Output 2009 2015

  • 393 Citations
  • 10 h-Index
  • 10 Article
39 Citations (Scopus)

5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits

Denise, C., Paoli, P., Calvani, M., Taddei, M. L., Giannoni, E., Kopetz, S., Kazmi, S. M. A., Pia, M. M., Pettazzoni, P., Sacco, E., Caselli, A., Vanoni, M., Landriscina, M., Cirri, P. & Chiarugi, P., Jan 1 2015, In : Oncotarget. 6, 39, p. 41706-41721 16 p.

Research output: Contribution to journalArticle

Fluorouracil
Colonic Neoplasms
Neoplasms
Recurrence
Pentose Phosphate Pathway
22 Citations (Scopus)

Characteristics of sweet syndrome in patients with acute myeloid leukemia

Kazmi, S. M., Pemmaraju, N., Patel, K. P., Cohen, P. R., Daver, N., Tran, K. M., Ravandi, F., Duvic, M., Garcia-Manero, G., Pierce, S., Nazha, A., Borthakur, G., Kantarjian, H. & Cortes, J., Jan 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 6, p. 358-363 6 p.

Research output: Contribution to journalArticle

Sweet Syndrome
Acute Myeloid Leukemia
Karyotype
Cytogenetics
Protein-Tyrosine Kinases
119 Citations (Scopus)

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

Morelli, M. P., Overman, M. J., Dasari, A., Kazmi, S. M. A., Mazard, T., Vilar, E., Morris, V. K., Lee, M. S., Herron, D., Eng, C., Morris, J., Kee, B. K., Janku, F., Deaton, F. L., Garrett, C., Maru, D., Diehl, F., Angenendt, P. & Kopetz, S., Jan 1 2015, In : Annals of Oncology. 26, 4, p. 731-736 6 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Mutation
DNA
Neoplasms
Monoclonal Antibodies
16 Citations (Scopus)

Outcomes among high-risk and standard-risk multiple myeloma patients treated with high-dose chemotherapy and autologous hematopoietic stem-cell transplantation

Kazmi, S. M., Nusrat, M., Gunaydin, H., Cornelison, A. M., Shah, N., Kebriaei, P., Nieto, Y., Parmar, S., Popat, U. R., Oran, B., Shah, J. J., Orlowski, R. Z., Champlin, R. E., Qazilbash, M. H. & Bashir, Q., Nov 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 11, p. 687-693 7 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Multiple Myeloma
Drug Therapy
Cytogenetics
Chromosome Aberrations
13 Citations (Scopus)

Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas

Raghav, K. P. S., Shetty, A. V., Kazmi, S. M. A., Zhang, N., Morris, J., Taggart, M., Fournier, K., Royal, R., Mansfield, P., Eng, C., Wolff, R. A. & Overman, M. J., Dec 16 2013, In : Oncologist. 18, 12, p. 1270-1277 8 p.

Research output: Contribution to journalArticle

Molecular Targeted Therapy
Cyclooxygenase 2
Adenocarcinoma
Microsatellite Instability
Mutation